| CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls M Weischer, SE Bojesen, C Ellervik, A Tybjærg-Hansen, ... Journal of Clinical Oncology 26 (4), 542-548, 2008 | 381 | 2008 |
| Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors IM Miller, C Ellervik, S Yazdanyar, GBE Jemec Journal of the American Academy of Dermatology 69 (6), 1014-1024, 2013 | 369 | 2013 |
| Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease J Brynskov, P Foegh, G Pedersen, C Ellervik, T Kirkegaard, A Bingham, ... Gut 51 (1), 37-43, 2002 | 272 | 2002 |
| RNA modifications by oxidation: a novel disease mechanism? HE Poulsen, E Specht, K Broedbaek, T Henriksen, C Ellervik, ... Free Radical Biology and Medicine 52 (8), 1353-1361, 2012 | 235 | 2012 |
| Association of metabolic syndrome and hidradenitis suppurativa IM Miller, C Ellervik, GR Vinding, K Zarchi, KS Ibler, KM Knudsen, ... JAMA dermatology 150 (12), 1273-1280, 2014 | 213 | 2014 |
| Factors associated with successful vaginal birth after a cesarean section: a systematic review and meta-analysis Y Wu, Y Kataria, Z Wang, WK Ming, C Ellervik BMC pregnancy and childbirth 19, 1-12, 2019 | 201 | 2019 |
| Preanalytical variables affecting the integrity of human biospecimens in biobanking C Ellervik, J Vaught Clinical chemistry 61 (7), 914-934, 2015 | 192 | 2015 |
| Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population S Cordua, L Kjaer, V Skov, N Pallisgaard, HC Hasselbalch, C Ellervik Blood, The Journal of the American Society of Hematology 134 (5), 469-479, 2019 | 187 | 2019 |
| Smoking and increased white and red blood cells: a mendelian randomization approach in the Copenhagen general population study KM Pedersen, Y Çolak, C Ellervik, HC Hasselbalch, SE Bojesen, ... Arteriosclerosis, thrombosis, and vascular biology 39 (5), 965-977, 2019 | 179 | 2019 |
| Hemochromatosis genotypes and risk of 31 disease endpoints: meta‐analyses including 66,000 cases and 226,000 controls C Ellervik, H Birgens, A Tybjærg‐Hansen, BG Nordestgaard Hepatology 46 (4), 1071-1080, 2007 | 179 | 2007 |
| The prevalence of inverse recurrent suppuration: a population‐based study of possible hidradenitis suppurativa GR Vinding, IM Miller, K Zarchi, KS Ibler, C Ellervik, GBE Jemec British Journal of Dermatology 170 (4), 884-889, 2014 | 172 | 2014 |
| Dairy intake and acne vulgaris: a systematic review and meta-analysis of 78,529 children, adolescents, and young adults CR Juhl, HKM Bergholdt, IM Miller, GBE Jemec, JK Kanters, C Ellervik nutrients 10 (8), 1049, 2018 | 170 | 2018 |
| Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study C Ellervik, T Mandrup-Poulsen, BG Nordestgaard, LE Larsen, ... The Lancet 358 (9291), 1405-1409, 2001 | 156 | 2001 |
| Iron regulation of pancreatic beta-cell functions and oxidative stress MB Backe, IW Moen, C Ellervik, JB Hansen, T Mandrup-Poulsen Annual Review of Nutrition 36 (1), 241-273, 2016 | 120 | 2016 |
| Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study M Ding, T Huang, HKM Bergholdt, BG Nordestgaard, C Ellervik, L Qi Bmj 356, 2017 | 112 | 2017 |
| Study design, participation and characteristics of the Danish General Suburban Population Study HK Bergholdt, L Bathum, J Kvetny, DB Rasmussen, B Moldow, T Hoeg, ... Dan Med J 60 (9), A4693, 2013 | 110 | 2013 |
| Milk intake is not associated with low risk of diabetes or overweight-obesity: a Mendelian randomization study in 97,811 Danish individuals HKM Bergholdt, BG Nordestgaard, C Ellervik The American journal of clinical nutrition 102 (2), 487-496, 2015 | 108 | 2015 |
| Estrogen receptor α polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case–control studies and a meta-analysis AD Kjaergaard, C Ellervik, A Tybjærg-Hansen, CK Axelsson, ... Circulation 115 (7), 861-871, 2007 | 106 | 2007 |
| Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study AL Sørensen, SU Mikkelsen, TA Knudsen, ME Bjørn, CL Andersen, ... haematologica 105 (9), 2262, 2020 | 105 | 2020 |
| Iron status and gestational diabetes—a meta-analysis Y Kataria, Y Wu, PH Horskjær, T Mandrup-Poulsen, C Ellervik Nutrients 10 (5), 621, 2018 | 95 | 2018 |
